Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077))

T. K. Schramm; G. H. Gislason; A. Vaag; J. N. Rasmussen; F. Folke; M. L. Hansen; E. L. Fosbøl; L. Køber; M. L. Norgaard; M. Madsen; P. R. Hansen; C. Torp-Pedersen

doi:10.1093/eurheartj/ehs127

Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077))

T. K. Schramm^*, G. H. Gislason, A. Vaag, J. N. Rasmussen, F. Folke, M. L. Hansen, E. L. Fosbøl, L. Køber, M. L. Norgaard, M. Madsen, P. R. Hansen, C. Torp-Pedersen

^*Corresponding author for this work

Original language	English
Journal	European Heart Journal
Volume	33
Issue number	10
Number of pages	1
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehs127
Publication status	Published - 1 May 2012

Access to Document

10.1093/eurheartj/ehs127

Cite this

Schramm, T. K., Gislason, G. H., Vaag, A., Rasmussen, J. N., Folke, F., Hansen, M. L., Fosbøl, E. L., Køber, L., Norgaard, M. L., Madsen, M., Hansen, P. R., & Torp-Pedersen, C. (2012). Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077)). European Heart Journal, 33(10). https://doi.org/10.1093/eurheartj/ehs127

Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077)). / Schramm, T. K.; Gislason, G. H.; Vaag, A. et al.
In: European Heart Journal, Vol. 33, No. 10, 01.05.2012.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Schramm, TK , Gislason, GH , Vaag, A, Rasmussen, JN, Folke, F , Hansen, ML , Fosbøl, EL , Køber, L, Norgaard, ML, Madsen, M , Hansen, PR & Torp-Pedersen, C 2012, 'Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077))', European Heart Journal, vol. 33, no. 10. https://doi.org/10.1093/eurheartj/ehs127

Schramm TK , Gislason GH , Vaag A, Rasmussen JN, Folke F , Hansen ML et al. Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077)). European Heart Journal. 2012 May 1;33(10). doi: 10.1093/eurheartj/ehs127

Schramm, T. K. ; Gislason, G. H. ; Vaag, A. et al. / Erratum : Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077)). In: European Heart Journal. 2012 ; Vol. 33, No. 10.

@article{fd52067e887c4d94925ddf6060c97a64,

title = "Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077))",

author = "Schramm, {T. K.} and Gislason, {G. H.} and A. Vaag and Rasmussen, {J. N.} and F. Folke and Hansen, {M. L.} and Fosb{\o}l, {E. L.} and L. K{\o}ber and Norgaard, {M. L.} and M. Madsen and Hansen, {P. R.} and C. Torp-Pedersen",

year = "2012",

month = may,

day = "1",

doi = "10.1093/eurheartj/ehs127",

language = "English",

volume = "33",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Erratum

T2 - Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077))

AU - Schramm, T. K.

AU - Gislason, G. H.

AU - Vaag, A.

AU - Rasmussen, J. N.

AU - Folke, F.

AU - Hansen, M. L.

AU - Fosbøl, E. L.

AU - Køber, L.

AU - Norgaard, M. L.

AU - Madsen, M.

AU - Hansen, P. R.

AU - Torp-Pedersen, C.

PY - 2012/5/1

Y1 - 2012/5/1

UR - http://www.scopus.com/inward/record.url?scp=84861401690&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehs127

DO - 10.1093/eurheartj/ehs127

M3 - Comment/debate

AN - SCOPUS:84861401690

SN - 0195-668X

VL - 33

JO - European Heart Journal

JF - European Heart Journal

IS - 10

ER -

Erratum: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study (European Heart Journal (2011) 32 (1900-1908) DOI: 10.1093/eurheartj/ehr077))

Access to Document

Other files and links

Cite this